Fluorine in PDB 4ncg: Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses

Enzymatic activity of Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses

All present enzymatic activity of Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses:
2.7.7.49; 2.7.7.7; 3.1.13.2; 3.1.26.13;

Protein crystallography data

The structure of Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses, PDB code: 4ncg was solved by Y.Yan, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 26.01 / 2.58
Space group C 2 2 21
Cell size a, b, c (Å), α, β, γ (°) 118.385, 153.618, 154.624, 90.00, 90.00, 90.00
R / Rfree (%) 21.7 / 26

Other elements in 4ncg:

The structure of Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses also contains other interesting chemical elements:

Chlorine (Cl) 1 atom

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses (pdb code 4ncg). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 3 binding sites of Fluorine where determined in the Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses, PDB code: 4ncg:
Jump to Fluorine binding site number: 1; 2; 3;

Fluorine binding site 1 out of 3 in 4ncg

Go back to Fluorine Binding Sites List in 4ncg
Fluorine binding site 1 out of 3 in the Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F601

b:66.5
occ:1.00
 F A:2KW601 0.0 66.5 1.0
C13 A:2KW601 1.3 61.3 1.0
F15 A:2KW601 2.1 58.9 1.0
F14 A:2KW601 2.1 62.8 1.0
C8 A:2KW601 2.3 58.5 1.0
O A:2KW601 2.8 61.5 1.0
C7 A:2KW601 2.9 58.7 1.0
N A:GLY190 3.1 70.2 1.0
C A:VAL189 3.1 73.0 1.0
C A:TYR188 3.2 68.4 1.0
N A:VAL189 3.3 67.1 1.0
O A:TYR188 3.3 67.5 1.0
C9 A:2KW601 3.4 59.0 1.0
O A:VAL189 3.5 72.2 1.0
CA A:GLY190 3.5 70.4 1.0
CA A:VAL189 3.6 67.5 1.0
CB A:TYR188 3.8 65.7 1.0
CG2 A:VAL106 3.9 83.4 1.0
CG1 A:VAL106 3.9 83.5 1.0
CA A:TYR188 3.9 64.5 1.0
C2 A:2KW601 4.0 66.6 1.0
C12 A:2KW601 4.3 58.1 1.0
O A:VAL179 4.4 70.7 1.0
CB A:VAL106 4.4 83.9 1.0
C10 A:2KW601 4.5 59.2 1.0
C1 A:2KW601 4.6 69.7 1.0
N11 A:2KW601 4.9 60.8 1.0
C A:GLY190 4.9 74.3 1.0
CD1 A:TYR181 4.9 72.1 1.0
C3 A:2KW601 4.9 67.0 1.0
CA A:VAL106 4.9 80.5 1.0

Fluorine binding site 2 out of 3 in 4ncg

Go back to Fluorine Binding Sites List in 4ncg
Fluorine binding site 2 out of 3 in the Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F601

b:62.8
occ:1.00
 F14 A:2KW601 0.0 62.8 1.0
C13 A:2KW601 1.4 61.3 1.0
F A:2KW601 2.1 66.5 1.0
F15 A:2KW601 2.2 58.9 1.0
C8 A:2KW601 2.4 58.5 1.0
O A:2KW601 2.7 61.5 1.0
C7 A:2KW601 2.9 58.7 1.0
CD1 A:TYR181 3.1 72.1 1.0
CB A:TYR188 3.2 65.7 1.0
C1 A:2KW601 3.2 69.7 1.0
C2 A:2KW601 3.3 66.6 1.0
O A:TYR188 3.4 67.5 1.0
C9 A:2KW601 3.5 59.0 1.0
CG A:TYR181 3.6 69.6 1.0
C A:TYR188 3.6 68.4 1.0
CB A:TYR181 3.6 65.2 1.0
CE1 A:TYR181 3.9 74.9 1.0
CA A:TYR188 4.0 64.5 1.0
CD2 A:LEU100 4.3 55.4 1.0
C12 A:2KW601 4.3 58.1 1.0
CG A:TYR188 4.4 67.0 1.0
N A:VAL189 4.4 67.1 1.0
C A:2KW601 4.5 69.2 1.0
N A:TYR181 4.5 62.2 1.0
C3 A:2KW601 4.6 67.0 1.0
CD2 A:TYR181 4.6 71.4 1.0
C10 A:2KW601 4.6 59.2 1.0
CG1 A:VAL179 4.7 74.0 1.0
CA A:TYR181 4.7 62.3 1.0
CD2 A:TYR188 4.8 67.8 1.0
N A:GLY190 4.8 70.2 1.0
CZ A:TYR181 4.9 81.0 1.0
N11 A:2KW601 4.9 60.8 1.0
C A:VAL189 5.0 73.0 1.0

Fluorine binding site 3 out of 3 in 4ncg

Go back to Fluorine Binding Sites List in 4ncg
Fluorine binding site 3 out of 3 in the Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 3 of Discovery of Doravirine, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F601

b:58.9
occ:1.00
 F15 A:2KW601 0.0 58.9 1.0
C13 A:2KW601 1.4 61.3 1.0
F A:2KW601 2.1 66.5 1.0
F14 A:2KW601 2.2 62.8 1.0
C8 A:2KW601 2.5 58.5 1.0
C9 A:2KW601 2.8 59.0 1.0
CG1 A:VAL179 3.3 74.0 1.0
CB A:VAL179 3.3 74.5 1.0
N A:GLY190 3.5 70.2 1.0
C7 A:2KW601 3.7 58.7 1.0
CA A:GLY190 3.7 70.4 1.0
CD1 A:TYR181 3.7 72.1 1.0
O A:VAL179 3.9 70.7 1.0
O A:TYR188 3.9 67.5 1.0
O A:2KW601 4.1 61.5 1.0
CE1 A:TYR181 4.2 74.9 1.0
C10 A:2KW601 4.2 59.2 1.0
CG2 A:VAL179 4.2 74.6 1.0
C A:VAL189 4.2 73.0 1.0
C A:VAL179 4.3 72.0 1.0
C A:TYR188 4.4 68.4 1.0
CA A:VAL179 4.4 70.6 1.0
CA A:VAL189 4.6 67.5 1.0
C A:GLY190 4.7 74.3 1.0
O A:GLY190 4.7 72.3 1.0
N A:VAL189 4.7 67.1 1.0
CG A:TYR181 4.8 69.6 1.0
CG A:LYS103 4.8 66.6 1.0
CG2 A:VAL106 4.8 83.4 1.0
C12 A:2KW601 4.9 58.1 1.0
O A:VAL189 5.0 72.2 1.0

Reference:

B.Cote, J.D.Burch, E.Asante-Appiah, C.Bayly, L.Bedard, M.Blouin, L.C.Campeau, E.Cauchon, M.Chan, A.Chefson, N.Coulombe, W.Cromlish, S.Debnath, D.Deschenes, K.Dupont-Gaudet, J.P.Falgueyret, R.Forget, S.Gagne, D.Gauvreau, M.Girardin, S.Guiral, E.Langlois, C.S.Li, N.Nguyen, R.Papp, S.Plamondon, A.Roy, S.Roy, R.Seliniotakis, M.St-Onge, S.Ouellet, P.Tawa, J.F.Truchon, J.Vacca, M.Wrona, Y.Yan, Y.Ducharme. Discovery of Mk-1439, An Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent Against A Wide Range of Resistant Mutant Hiv Viruses. Bioorg.Med.Chem.Lett. V. 24 917 2014.
ISSN: ISSN 0960-894X
PubMed: 24412110
DOI: 10.1016/J.BMCL.2013.12.070
Page generated: Sun Dec 13 12:08:52 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy